Immutep Limited
PRRUF
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 23.42% | 16.43% | 6.69% | -5.09% | -13.74% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 23.42% | 16.43% | 6.69% | -5.09% | -13.74% |
Cost of Revenue | 22.40% | 18.01% | 11.64% | 5.93% | 1.12% |
Gross Profit | -22.28% | -18.19% | -12.17% | -7.28% | -3.19% |
SG&A Expenses | -12.01% | -5.90% | -0.70% | 11.56% | 27.55% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 15.56% | 13.32% | 9.26% | 6.94% | 5.46% |
Operating Income | -14.85% | -13.05% | -9.47% | -8.12% | -7.65% |
Income Before Tax | -7.60% | -6.74% | -4.31% | -4.80% | -6.28% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -7.60% | -6.74% | -4.31% | -4.80% | -6.28% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -7.60% | -6.74% | -4.31% | -4.80% | -6.28% |
EBIT | -14.85% | -13.05% | -9.47% | -8.12% | -7.65% |
EBITDA | -17.63% | -14.70% | -9.90% | -8.66% | -8.72% |
EPS Basic | 16.15% | 19.29% | 22.85% | 17.17% | 10.96% |
Normalized Basic EPS | 16.67% | 19.54% | 22.46% | 16.85% | 10.50% |
EPS Diluted | 16.15% | 19.29% | 22.85% | 17.17% | 10.96% |
Normalized Diluted EPS | 16.67% | 19.54% | 22.46% | 16.85% | 10.50% |
Average Basic Shares Outstanding | 27.30% | 30.65% | 34.59% | 27.89% | 20.99% |
Average Diluted Shares Outstanding | 27.30% | 30.65% | 34.59% | 27.89% | 20.99% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |